1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Puerto Rico Pharmaceuticals and Healthcare Report Q3 2016

Puerto Rico Pharmaceuticals and Healthcare Report Q3 2016

  • July 2016
  • -
  • Business Monitor International
  • -
  • 89 pages

Includes 3 FREE quarterly updates

BMI View: Puerto Rico's importance as a major production hub for multinational pharmaceuticalcompanies will moderate owing to drug patent expirations, production quality issues and a potential taxincrease from the local government. However, relatively low production costs and a skilled workforce willcontinue to attract multinational pharmaceutical investment to the island, as illustrated by recentinvestment projects announced by US and European drugmakers including Bristol-Myers Squibb, Rocheand Sartorius. Meanwhile, Puerto Rico's domestic pharmaceutical and healthcare market is expected toexpand modestly over the forecast period, albeit facing headwinds due to an internal devaluation andpublic expenditure cuts triggered by government debt restructuring.Headline Expenditure Projections

- Pharmaceuticals: USD3.81bn in 2015 to USD3.82bn in 2016; +0.2%. Forecast revised slightlydownwards from last quarter.

- Healthcare: USD8.06bn in 2015 to USD8.38bn in 2016; +3.9%. Forecast in line with last quarter.

Table Of Contents

Puerto Rico Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Puerto Rico 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Puerto Rico 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Puerto Rico 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2012-2020) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Puerto Rico 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Puerto Rico 2014-2020) 29
Pharmaceuticals and Healthcare Risk/Reward Index 30
Americas Risk/Reward Index 30
Puerto Rico Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 37
Table: Incentives, Benefits And Discounts For Pharmaceutical Manufacturers 39
Pricing Regime 40
Reimbursement Regime 41
Market Overview 42
Healthcare Sector 43
Research and Development 47
Clinical Trials 49
Epidemiology 50
Competitive Landscape 53
Research-Based Industry 54
Table: Major International Drugmakers In Puerto Rico 54
Table: Puerto Rico - Multinationals' Operations 57
Table: Multinational Company Activity, 2015 58
Generic Drugmakers 59
Pharmaceutical Distribution 60
Pharmaceutical Retail Sector 60
Company Profile 62
Abbott Laboratories 62
Eli Lilly 65
GlaxoSmithKline 68
Merck 71
Novartis 74
Sanofi 76
Demographic Forecast 78
Table: Population Headline Indicators (Puerto Rico 1990-2025) 79
Table: Key Population Ratios (Puerto Rico 1990-2025) 79
Table: Urban/Rural Population and Life Expectancy (Puerto Rico 1990-2025) 80
Table: Population By Age Group (Puerto Rico 1990-2025) 80
Table: Population By Age Group % (Puerto Rico 1990-2025) 81
Glossary 83
Methodology 85
Pharmaceutical Expenditure Forecast Model 85
Healthcare Expenditure Forecast Model 85
Notes On Methodology 86
Risk/Reward Index Methodology 87
Index Overview 88
Table: Pharmaceutical Risk/Reward Index Indicators 88
Indicator Weightings 89

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.